Generic Products

Taj products add value to healthcare systems by providing high quality medicines that are affordable. With a diverse and rapidly growing product range, we cover a number of therapeutic segments.

Over The Counter medicines/ formulations

The Quality Driven Values at Taj has fuelled our growth in recent years, in the challenging environment of generic markets in the UK we continue to grow our OTC brands to supplement this generic activity..

Products

Our diverse range of products manufactured by our parent company Taj Pharma Limited is a testimony to our commitment to make a positive contribution to the healthcare system. We are constantly evaluating the feasibility of products designed to reduce the cost of manufacturing, while retaining the safety and efficacy of the product molecule. There is a constant endeavour to formulate newer generics and make them available to the health care providers.

Our finished dosage form products, due to our quality driven value system ensures that the product made available to the consumer is of the highest standard of quality and efficacy.

Taj Pharma UK Limited play a small but important role in the UK generic market. It has a diverse product portfolio of 64 molecules, 84 licenses offering over 400 presentations, with more in the pipeline. We are focused on developing/acquiring more generics across the range.

Taj’s wide range of products covers the following therapeutic classes:

• • Analgesics

• • Anti-Infectives

• • Anti hypertensives

• • Anti depressants

• Anti spasmodics

Chemotherapy-Induced Nausea and Vomiting

Nausea and vomiting continues to affect patients undergoing cancer therapy.

Chemotherapy-Induced Nausea and Vomiting are a common side-effects of cancer treatments. Nausea and vomiting are two of the most feared cancer treatment-related side effects for cancer patients and their families. In 1983, Coates et al. found that patients receiving chemotherapy ranked nausea and vomiting as the first and second most severe side effects, respectively. Up to 20% of patients receiving highly emetogenic agents in this era postponed, or even refused, potentially curative treatments.

Since the 1990s, several novel classes of antiemetics have been developed and commercialized, becoming a nearly universal standard in chemotherapy regimens, and helping to better manage these symptoms in a large portion of patients. Management of these unpleasant and sometimes crippling symptoms results in increased quality of life for the patient, and better overall health of the patient, and, due to better patient tolerance, more effective treatment cycles.

Many valuable development opportunities get lost in translation from academia to industry. Taj Pharma is dedicated to identifying these opportunities and ensuring that the value in the underlying pharmaceutical assets is preserved. We achieve this through alignment of IP and licencing strategies with the drug development process.

Taj Pharma team are highly qualified and experienced, and supported by a large network of skilled independent industry experts.

With agility that is unparalleled in the industry, we are ready to help guide viable projects into market-ready products and ensure that the true value of innovation is retained.

Approximately 1 in 6 people will suffer major depression at one point in their lives, and while there are various antidepressants on the market, many patients remain severely undertreated.

Current first-line therapies take between 3 and 12 weeks to work, and it is often during this long lag-time that the most debilitating symptoms of depression occur. In addition, around 40% of patients remain clinically ill after a year of treatment, highlighting the urgent need for alternative therapies.

We have identified an innovative solution to bridge this gap by developing a rapid-acting antidepressant.

Taj Pharma Services has manufactured a wide range of solid dose, powders and hard gel capsules since 1995. Our facilities can manufacture existing and new formulations, providing innovative solutions for your hard-to-manufacture products. We have licences for the manufacture of hormones, controlled drugs, specials and investigational medicinal products (IMPs). Our facilities and services are certified by the Food and Drug Regulatory Agency (FDA).

Taj Pharma Services project managers form a critical part of each project, ensuring that every programme is delivered on time and in full. Your project manager will coordinate every process in each phase of your programme to meet your timelines and budget. As a key member of your product and process development team, your project manager will ensure all your technical requirements are met and will work with you to resolve any regulatory challenge you encounter.

All of our project managers have more than a decade of experience within the pharmaceutical industry, having managed programmes from both clinical and commercial sectors. Custom requires that our project managers be certified to apply these principles across all our client programmes. Taj also ensures that the team is highly knowledgeable in the principles of Good Manufacturing Practices, Good Distribution Practices and clinical trial supply management.

Taj consider our work to help bring lifesaving and life-enhancing products to the market to be an honour. That’s why our project managers treat every programme as if it is their own. Taj will communicate with you at every stage, updating you on the progress of your project at every stage throughout the development life cycle and responding quickly and appropriately to your specific needs.

Labels: taj pharmaceuticals limited, taj pharmaceuticals limited Bombay, taj pharmaceuticals limited mumbai, taj pharmaceuticals limited promoters, taj pharmaceuticals promoters, taj pharma promoters, taj pharma Bombay, Taj Pharmaceuticals mumbai, Taj Pharmaceuticals Bombay